Hunter Meyer News Today

Dr. Hunter Meyer, MD, has joined the team of surgeons at AdventHealth Medical Group General Surgery at Calhoun.

AdventHealth Medical Group is pleased to welcome Hunter Meyer, MD, to its renowned team of surgeons at AdventHealth Medical Group General Surgery at Calhoun. Dr.

Luther's spring 2021 opera production of "Dido and Aeneas" won first place in the national competition.

Storytelling with Images at Luther During the Pandemic The ideas and viewpoints expressed in the posts on the Ideas and Creations blog are solely the view of the author(s). Luther Colleges mission statement calls us to "embrace diversity and challenge one another to learn in community," and to be "enlivened and transformed by encounters with one another, by the exchange of ideas, and by the life of faith and learning." Alumni, faculty, staff, students and friends of the college are encouraged t...

Published: May 13, 2021 By Kate Goodwin There are more than 7,000 rare diseases identified in the world today. While “rare” means that less than 200,000 people in the US are affected, to suffer from a rare disease is not actually rare at all.  Around 10% of the American population suffers from a rare disease. A shocking 90% of rare diseases do not have an approved treatment on the market.  A  first-of-its-kind organization launched today unifying the voices of life science compa...

Published: May 13, 2021 By Kate Goodwin There are more than 7,000 rare diseases identified in the world today. While “rare” means that less than 200,000 people in the US are affected, to suffer from a rare disease is not actually rare at all.  Around 10% of the American population suffers from a rare disease. A shocking 90% of rare diseases do not have an approved treatment on the market.  A  first-of-its-kind organization launched today unifying the voices of life science compa...

LESSWRONG 38 Key Points Theoretical & empirical work on emotional valence is Qualia Research Institute’s core research focus. At a high level, Qualia Research Institute (QRI) works to formulate universal theories of valence [1], test those theories experimentally, and build non-invasive neurotechnology that reliably produces large positive valence effects. QRI has formed partnerships to work with clinical data from psychedelic studies at Kings College London, Imperial College London, and the ...